InvestorsHub Logo
Followers 1
Posts 234
Boards Moderated 0
Alias Born 10/03/2014

Re: Polyphemus post# 869

Sunday, 04/17/2022 11:31:25 AM

Sunday, April 17, 2022 11:31:25 AM

Post# of 1032
Polyphemus, I agree with most everything that you post. I thank you for sharing your expert opinion. Not disagreeing with your strategy, but am still concerned about the time horizon. It might take longer to implement your strategy due to clinicians habit of utilizing pharmaceutical solutions. We recognize that stimulating the nerve produces the desired patient I response with close to zero side effects. It is still very difficult to convince clinicians to utilize a new, albeit better, treatment modality.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ECOR News